These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34237655)

  • 1. Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study.
    Guiraud J; Addolorato G; Aubin HJ; Batel P; de Bejczy A; Caputo F; Goudriaan AE; Gual A; Lesch O; Maremmani I; Perney P; Poulnais R; Raffaillac Q; Soderpalm B; Spanagel R; Walter H; van den Brink W;
    Eur Neuropsychopharmacol; 2021 Nov; 52():18-30. PubMed ID: 34237655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial.
    Guiraud J; Addolorato G; Antonelli M; Aubin HJ; de Bejczy A; Benyamina A; Cacciaglia R; Caputo F; Dematteis M; Ferrulli A; Goudriaan AE; Gual A; Lesch OM; Maremmani I; Mirijello A; Nutt DJ; Paille F; Perney P; Poulnais R; Raffaillac Q; Rehm J; Rolland B; Rotondo C; Scherrer B; Simon N; Skala K; Söderpalm B; Somaini L; Sommer WH; Spanagel R; Vassallo GA; Walter H; van den Brink W
    J Psychopharmacol; 2022 Oct; 36(10):1136-1145. PubMed ID: 35796481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment Duration.
    Guiraud J; Addolorato G; Aubin HJ; Bachelot S; Batel P; de Bejczy A; Benyamina A; Caputo F; Couderc M; Dematteis M; Goudriaan AE; Gual A; Lecoustey S; Lesch OM; Maremmani I; Nutt DJ; Paille F; Perney P; Rehm J; Rolland B; Scherrer B; Simon N; Söderpalm B; Somaini L; Sommer WH; Spanagel R; Walter H; van den Brink W
    Alcohol Alcohol; 2023 Mar; 58(2):125-133. PubMed ID: 36617267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence.
    Keating GM
    Clin Drug Investig; 2014 Jan; 34(1):63-80. PubMed ID: 24307430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjects.
    Addolorato G; Lesch OM; Maremmani I; Walter H; Nava F; Raffaillac Q; Caputo F
    Expert Opin Drug Saf; 2020 Feb; 19(2):159-166. PubMed ID: 31876433
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacodynamic interactions of a solid formulation of sodium oxybate and ethanol in healthy volunteers.
    Pross N; Patat A; Vivet P; Bidaut M; Fauchoux N
    Br J Clin Pharmacol; 2015 Sep; 80(3):480-92. PubMed ID: 25782469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity.
    Caputo F; Francini S; Brambilla R; Vigna-Taglianti F; Stoppo M; Del Re A; Leggio L; Addolorato G; Zoli G; Bernardi M
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):450-6. PubMed ID: 21276717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level.
    van den Brink W; Addolorato G; Aubin HJ; Benyamina A; Caputo F; Dematteis M; Gual A; Lesch OM; Mann K; Maremmani I; Nutt D; Paille F; Perney P; Rehm J; Reynaud M; Simon N; Söderpalm B; Sommer WH; Walter H; Spanagel R
    Addict Biol; 2018 Jul; 23(4):969-986. PubMed ID: 30043457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
    Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention.
    Skala K; Caputo F; Mirijello A; Vassallo G; Antonelli M; Ferrulli A; Walter H; Lesch O; Addolorato G
    Expert Opin Pharmacother; 2014 Feb; 15(2):245-57. PubMed ID: 24283802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium oxybate in the treatment of alcohol withdrawal syndrome: a randomized double-blind comparative study versus oxazepam. The GATE 1 trial.
    Caputo F; Skala K; Mirijello A; Ferrulli A; Walter H; Lesch O; Addolorato G
    CNS Drugs; 2014 Aug; 28(8):743-52. PubMed ID: 24996524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.
    Caputo F; Vignoli T; Tarli C; Domenicali M; Zoli G; Bernardi M; Addolorato G
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26959045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
    Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Russell IJ; Perkins AT; Michalek JE;
    Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
    Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
    Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel strategies to treat alcohol dependence with sodium oxybate according to clinical practice.
    Caputo F; Mirijello A; Cibin M; Mosti A; Ceccanti M; Domenicali M; Bernardi M; Maremmani I; Addolorato G;
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1315-20. PubMed ID: 25912595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group
    Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.